TC
Tejara Capital Portfolio holdings
AUM
$216M
This Quarter Return
+8.5%
1 Year Return
-14.3%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$176M
AUM Growth
+$176M
(-13%)
Cap. Flow
-$59.6M
Cap. Flow
% of AUM
-33.91%
Top 10 Holdings %
Top 10 Hldgs %
51.52%
Holding
86
New
15
Increased
19
Reduced
18
Closed
21
Top Buys
| 1 |
Citigroup
C
|
$18.8M |
| 2 |
Peabody Energy
BTU
|
$5.54M |
| 3 |
AGNC Investment
AGNC
|
$3.3M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$3M |
| 5 |
Hertz
HTZ
|
$2.76M |
Top Sells
| 1 |
CNR
Core Natural Resources, Inc.
CNR
|
$29.2M |
| 2 |
Valaris
VAL
|
$9.59M |
| 3 |
Noble Corp
NE
|
$9.52M |
| 4 |
Cameco
CCJ
|
$7.37M |
| 5 |
Nabors Industries
NBR
|
$7.02M |
Sector Composition
| 1 | Energy | 40.74% |
| 2 | Healthcare | 25.35% |
| 3 | Financials | 15.5% |
| 4 | Industrials | 6.34% |
| 5 | Materials | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Citigroup
C
$178B
| $18.8M | 10.64% | +456,311 | New | +$18.8M |
|
2
Golar LNG
GLNG
$4.48B
| $12.3M | 6.99% | 508,280 -209,158 | -29% | -$5.07M |
|
|
3
Peabody Energy
BTU
$2.12B
| $9.1M | 5.16% | 350,290 +213,125 | +155% | +$5.54M |
|
|
BORR
4
Borr Drilling
BORR
$833M
| $8.66M | 4.91% | 1,219,305 +192,649 | +19% | +$1.37M |
|
|
5
Teva Pharmaceuticals
TEVA
$21.1B
| $8.39M | 4.76% | 822,495 +293,900 | +56% | +$3M |
|
|
6
Cameco
CCJ
$33.7B
| $7.36M | 4.17% | 185,651 -185,850 | -50% | -$7.37M |
|
7
NOV
NOV
$4.94B
| $7.13M | 4.04% | 341,065 -250,000 | -42% | -$5.23M |
|
|
8
Nabors Industries
NBR
$543M
| $6.64M | 3.76% | 53,901 -57,046 | -51% | -$7.02M |
|
9
Collegium Pharmaceutical
COLL
$1.22B
| $6.48M | 3.67% | 289,803 -14,886 | -5% | -$333K |
|
|
CNR
10
Core Natural Resources, Inc.
CNR
$3.82B
| $5.74M | 3.26% | 54,755 -278,497 | -84% | -$29.2M |
|
11
Forum Energy Technologies
FET
$315M
| $5.02M | 2.85% | 209,090 | – | – |
|
12
BGC Group
BGC
$4.65B
| $4.85M | 2.75% | 918,812 +10,000 | +1% | +$52.8K |
|
13
Viatris
VTRS
$12.3B
| $4.6M | 2.61% | 466,715 +165,000 | +55% | +$1.63M |
|
14
Roivant Sciences
ROIV
$8.15B
| $4.19M | 2.37% | 358,572 +118,665 | +49% | +$1.39M |
|
|
MREO
15
Mereo BioPharma
MREO
$272M
| $4.15M | 2.35% | 3,215,001 +177,030 | +6% | +$228K |
|
16
Scorpio Tankers
STNG
$2.57B
| $3.63M | 2.06% | 67,121 +10,000 | +18% | +$541K |
|
17
Oportun Financial
OPRT
$291M
| $3.63M | 2.06% | 502,651 +25,000 | +5% | +$181K |
|
18
The GEO Group
GEO
$2.94B
| $3.34M | 1.89% | 408,244 -49,525 | -11% | -$405K |
|
|
19
AGNC Investment
AGNC
$10.2B
| $3.3M | 1.87% | +349,444 | New | +$3.3M |
|
|
20
Hertz
HTZ
$1.78B
| $2.76M | 1.56% | +225,000 | New | +$2.76M |
|
21
Orthofix Medical
OFIX
$592M
| $2.7M | 1.53% | +209,795 | New | +$2.7M |
|
22
Kenvue
KVUE
$39.7B
| $2.51M | 1.42% | +125,000 | New | +$2.51M |
|
23
Mativ Holdings
MATV
$687M
| $2.35M | 1.33% | +165,105 | New | +$2.35M |
|
24
Fluor
FLR
$6.63B
| $2.2M | 1.25% | 60,000 -28,775 | -32% | -$1.06M |
|
25
Heron Therapeutics
HRTX
$207M
| $2.17M | 1.23% | 2,109,681 +469,548 | +29% | +$484K |
|